Aiming at characterizing the subset of ACTBL2-expressing TILs in epithelial ovarian cancer with special regard to putative immune-mediated antitumoral effects, immunofluorescence double-staining was performed. This evidence concerns the gene ACTBL2 and ovarian carcinoma.